Bradley A Tate is a Vancouver, Washington based male eyecare provider who is specialized as Optician. Active license number of Bradley A Tate is CERTEFIED for Optician in Oregon. Bradley A Tate makes / sells eyeglasses and, contact lenses, for remedying defects of vision in accordance with the prescriptions of ophthalmologists and optometrists. Opticians also specializes in filling lens prescriptions, assisting patients with lens and frame selection and fitting (including style, weight and colour) but they do not test vision or write prescriptions for visual correction.
Complete Profile:
Bradley A Tate speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Optician
Gender:
Male
Practice Address:
14406 Ne 20th Ave, Vancouver, Washington, 98686-1448
Phone:
360-571-3084
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1225147218
NPI Enumeration Date:
30 Aug, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Bradley A Tate are as mentioned below.
License Number
Specialization
State
Status
CERTEFIED
Optician
Oregon
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
15311 Se Bybee Dr, Portland, Oregon
Zip:
97236-7858
Phone Number:
503-621-6889
Fax Number:
--
Patients can reach Bradley A Tate at 14406 Ne 20th Ave, Vancouver, Washington or can call to book an appointment on 360-571-3084. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.